FREXCITE
Live / Applied — Statement of use — processing complete, to examiner (as of 05 Nov 2026)
What this means for you
Not registered yet, but its 03 Oct 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99426423
- Mark type
- Design + words
- Filed
- 03 Oct 2025
- Published for opposition
- 24 Mar 2026
- Attorney of record
- Alexandra Kochian
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials
Owner
- Genzyme Corporation, Cambridge, MA, US
- Genzyme Corporation, Cambridge, MA, US
Prosecution history
- 05 Nov 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Nov 2026 — USE AMENDMENT FILED
- 05 Nov 2026 — TEAS STATEMENT OF USE RECEIVED
- 31 Oct 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Oct 2026 — SOU EXTENSION 1 GRANTED
- 30 Oct 2026 — SOU EXTENSION 1 FILED
- 30 Oct 2026 — SOU TEAS EXTENSION RECEIVED
- 28 Sept 2026 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 19 May 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Mar 2026 — PUBLISHED FOR OPPOSITION
- 18 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Feb 2026 — EXAMINER'S AMENDMENT ENTERED
- 26 Feb 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED